MEDICINE

Roklan Plus

0.02% + 0.005% Ophthalmic Solution · Netarsudil + Latanoprost

Indications

This is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Pharmacology

This is a fixed-dose combination of a Rho kinase inhibitor and a Prostaglandin F2 analogue. Netarsudil is a Rho kinase inhibitor, works at the cellular level within the trabecular outflow pathway to relax actin-myosin. This causes relaxation within the trabecular meshwork and the inner wall of Schlemm's canal, and decrease episcleral venous pressure (EVP). Latanoprost is a selective FP receptor agonist which reduces the intraocular pressure (IOP) by increasing the outflow of aqueous humor through uveoscleral outflow.

Dosage and administration

The recommended dosage is one drop in the affected eye(s) once daily in the evening. Pediatric Use : Safety and effectiveness in pediatric patients have not been established. Use in elderly patients : No overall differences in safety and effectiveness have been observed between elderly and other adult patients.

Contraindications

This eye drops is contraindicated in patients who are hypersensitive to any component of this preparation.

Side effects

The most common ocular adverse reaction observed in controlled clinical studies with Netarsudil & Latanoprost was conjunctival hyperemia, instillation site pain, corneal verticillata, instillation site discomfort, foreign body sensation and blurred visions were reported in few patients.

Pregnancy and lactation

There are no adequate and well-controlled studies of Netarsudil & Latanoprost combination in pregnant women to inform any drug-associated risk. There are no data on the presence of Netarsudil or Latanoprost in human milk, the effects on the breastfed infant, or the effects on milk production.

Precautions and warnings

For ophthalmic use only

To avoid possible contamination of the drops, do not touch the dropper tip or to any surface

Should be used with caution in patients with active intraocular inflammation (e.g., iritis/uveits)

May cause changes to pigmented tissues, gradually change eyelashes and vellus hair in the treated eye

Cystoid macular edema, has been reported during treatment with Latanoprost. Reactivation of Herpes Simplex keratitis may occur

Netarsudil & Latanoprost combination can be used with other topical eye drug products, but they should be administered at least 5 minutes apart from each other.

Storage

Store at 2°-8°C in a dry place, protect from light until opened. After opening the product may be kept at 2°-25°C for upto 6 weeks. Keep out of the reach of children.

Similar brands of Netarsudil + Latanoprost

Brands of Netarsudil + Latanoprost
#BrandCompanyFormStrengthPrice
1Nesudil PlusAristopharma Ltd.Ophthalmic Solution0.02% + 0.005%Not listed
2Rsudil plusThe IBN SINA Pharmaceutical PLCOphthalmic Solution0.02% + 0.005%Not listed
See every brand of Netarsudil + Latanoprost →

Common questions

What is Roklan Plus used for?

This is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

What is the generic name of Roklan Plus?

Roklan Plus contains Netarsudil + Latanoprost, which belongs to the group: Drugs for miotics and glaucoma.

Who makes Roklan Plus?

Roklan Plus is marketed in Bangladesh by Popular Pharmaceuticals Ltd..

How is Roklan Plus taken?

The recommended dosage is one drop in the affected eye(s) once daily in the evening. Pediatric Use : Safety and effectiveness in pediatric patients have not been established. Always follow your doctor's instructions.

What are the side effects of Roklan Plus?

The most common ocular adverse reaction observed in controlled clinical studies with Netarsudil & Latanoprost was conjunctival hyperemia, instillation site pain, corneal verticillata, instillation site discomfort, foreign body sensation and blurred visions were reported in few patients.

Is Roklan Plus safe in pregnancy?

There are no adequate and well-controlled studies of Netarsudil & Latanoprost combination in pregnant women to inform any drug-associated risk. There are no data on the presence of Netarsudil or Latanoprost in human milk, the effects on the breastfed infant, or the effects on milk production. Ask your doctor before using it while pregnant or breastfeeding.

This page is general information and is not medical advice. It does not replace a registered doctor, and it is not a prescription or a recommendation to use any medicine or test. Prices are listed prices and may change. Always follow the advice of your doctor or pharmacist.